Medical Technology Executive Forum 2009

Date:

Thu, 09/17/2009 - 3:24pm

This one day interactive workshop provided CEOs and senior medical technology executives with a practical perspective on managing the key issues that directly impact successful product commercialization. Industry experts addressed attracting and securing funding, recent developments at FDA, navigating reimbursement challenges, protecting and licensing IP and much more. In addition, speakers discussed managing these key elements as a company plans for the successful launch of new products and technologies.

September 17, 2009
Crowne Plaza Hotel - Palo Alto
4290 El Camino Real
Palo Alto, CA 94306

Agenda

8:00-8:30 am

Registration and Continental Breakfast

8:30-8:45 am

Welcome and Opening Remarks

Mark Leahey, President and CEO, MDMA

8:45–9:30 am

Attracting Funding and Deal Design
Panelists will discuss a variety of funding options for emerging companies in this difficult economic environment.

Andrew Cleeland, President and CEO, Ardian Inc.
J. Casey McGlynn, Partner and Chairman Life Sciences Group, Wilson Sonsini Goodrich & Rosati
Kevin Wasserstein, Managing Director, Versant Ventures

9:30-10:15 am

Protecting Your Technology in the Changing IP Environment

Learn the latest strategies to protect one of your company’s greatest assets, IP.

Earl "Eb" Bright, General Counsel and VP, Intellectual Property, Exploramed
Sabing Lee, Partner, Knobbe Martens

10:15-10:45 am

Networking Break

10:45-11:30 am

Understanding Product Development Options
In an era when conserving cash is critical, learn effective and efficient product development options.

Creating Internal Development Capabilities: How to Launch a High Quality Product on Time, Todd Sloan, Vice President, Professional Marketing and Product Development, Conceptus Inc.
Outsourcing Product Development, Bob Chapman, Product Development Division, MPR Associates, Inc.

11:30-12:30 pm

Navigating the FDA Process
This session will focus on the changing landscape at FDA and how companies should respond.

Donna-Bea Tillman, PhD, Director, Office of Device Evaluation, Center for Devices and Radiological Health

12:30-1:30 pm

Networking Luncheon

1:30-2:00 pm

Discussion of the Latest on Healthcare Reform
Update on Physician Sunshine Act, Payment Reform, and Comparative Effectiveness

Mark Leahey, President and CEO, MDMA

2:00-3:00 pm

Reimbursement Opportunities and Challenges

Timely and Adequate reimbursement is vital to emerging companies. Learn from experts about the latest trends and strategies in how to succeed in this critical space.

Grant Bagley, Partner, HillCo Partners
Bill Facteau, Chief Executive Officer, Acclarent, Inc.
Thomas Novelli, Director of Federal Affairs, MDMA

3:00–3:45 pm

Developting a Compliance Program

Discuss of appropriate interactions between sales professionals and healthcare practitioners (HCPs)

Kathy Lauer, Partner, Latham and Watkins

Open Question and Answer

Presentations

Protecting Your Technology in the Changing Environment

Earl "Eb" Bright, General Counsel and VP, Intellectual Property, Exploramed
Sabing Lee, Partner, Knobbe Martens

Understanding Product Development Options

Creating Internal Development Capabilities: How to Launch a High Quality Product on Time, Todd Sloan, Vice President, Professional Marketing and Product Development, Conceptus Inc.
Outsourcing Product Development: The Virtual Company Revolution, Bob Chapman, Product Development Division, MPR Associates, Inc.

Navigating the FDA Process

Donna-Bea Tillman, PhD, Director, Office of Device Evaluation, CDRH

Discussion of the Latest on Healthcare Reform

Mark B. Leahey, President and CEO, MDMA